Drug Shortage Report for ACT AMPHETAMINE XR

Last updated on 2021-05-20 History
Report ID 136286
Drug Identification Number 02439271
Brand name ACT AMPHETAMINE XR
Common or Proper name AMPHETAMINE XR 25MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MIXED SALTS AMPHETAMINE
Strength(s) 25MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2021-03-24
Estimated end date 2021-05-31
Actual end date 2021-05-19
Shortage status Resolved
Updated date 2021-05-20
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-05-20 French Compare
v7 2021-05-20 English Compare
v6 2021-05-10 French Compare
v5 2021-05-10 English Compare
v4 2021-05-06 French Compare
v3 2021-05-06 English Compare
v2 2021-03-25 French Compare
v1 2021-03-25 English Compare